Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis

Journal of Pathology

Volumn 224, Issue 2, 2011, Pages 261-269

  Cheng, Ching Wen ^a   Licence, Diana ^a   Cook, Emma ^a   Luo, Feijun ^a   Arends, Mark J ^a   Smith, Stephen K ^a,c   Print, Cristin G ^a,d   Charnock Jones, D Stephen ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

endometriosis; immunocompetent hormone; model; ras

Indexed keywords

BETA GALACTOSIDASE; ESTRADIOL; FULVESTRANT; K RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INVASION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENETIC RECOMBINATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN ANTAGONISTS; EXTRACELLULAR MATRIX; FEMALE; GENES, RAS; IMMUNOCOMPETENCE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; RECEPTORS, ESTROGEN; STROMAL CELLS;

EID: 79955824827     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2852     Document Type: Article

References (40)

1. Houston DE,. Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev 1984; 6: 167-191. (Pubitemid 14024793)
2. Hadfield R, Mardon H, Barlow D, et al., Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod 1996; 11: 878-880. (Pubitemid 26142192)
3. Simoens S, Hummelshoj L, D'Hooghe T,. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007; 13: 395-404. (Pubitemid 47062831)
4. Bulun SE,. Endometriosis. N Engl J Med 2009; 360: 268-279.
5. Giudice LC, Kao LC,. Endometriosis. Lancet 2004; 364: 1789-1799. (Pubitemid 39488065)
6. Grummer R,. Animal models in endometriosis research. Hum Reprod Update 2006; 12: 641-649. (Pubitemid 44288713)
7. Brinton LA, Gridley G, Persson I, et al., Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997; 176: 572-579. (Pubitemid 27147164)
8. Melin A, Sparen P, Persson I, et al., Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006; 21: 1237-1242.
9. Ogawa S, Kaku T, Amada S, et al., Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000; 77: 298-304. (Pubitemid 30317153)
10. Bast RC Jr, Hennessy B, Mills GB,. The biology of ovarian cancer: new opportunities for translation. Nature Rev Cancer 2009; 9: 415-428.
11. Zorn KK, Bonome T, Gangi L, et al., Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 2005; 11: 6422-6430. (Pubitemid 41338978)
12. Kobel M, Kalloger SE, Boyd N, et al., Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 2008; 5: e232.
13. Ahmed AA, Etemadmoghadam D, Temple J, et al., Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol 2010; 221: 49-56.
14. Press JZ, De Luca A, Boyd N, et al., Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer 2008; 8: 17.
15. Wiegand KC, Shah SP, Al-Agha OM, et al., ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363: 1532-1543.
16. Kuo KT, Mao TL, Jones S, et al., Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol 2009; 174: 1597-1601.
17. Jones S, Wang TL, Shih I, et al., Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science (NY) 2010; 330: 228-231.
18. Mackay HJ, Brady MF, Oza AM, et al., Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer 2010; 20: 945-952.
19. Heyer J, Kwong LN, Lowe SW, et al., Non-germline genetically engineered mouse models for translational cancer research. Nature Rev Cancer 2010; 10: 470-480.
20. Sharpless NE, Depinho RA,. The mighty mouse: genetically engineered mouse models in cancer drug development. Nature Rev Drug Discovery 2006; 5: 741-754. (Pubitemid 44323701)
21. Van Dyke T, Jacks T,. Cancer modeling in the modern era: progress and challenges. Cell 2002; 108: 135-144. (Pubitemid 34161134)
22. Frese K, Tuveson D,. Maximizing mouse cancer models. Nature Rev Cancer 2007; 7: 645-658. (Pubitemid 47327410)
23. Akyol A, Hinoi T, Feng Y, et al., Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nature Methods 2008; 5: 231-233. (Pubitemid 351325645)
24. DuPage M, Dooley AL, Jacks T,. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nature Protocols 2009; 4: 1064-1072.
25. Zhou Y, Rideout WM, Zi T, et al., Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nature Biotechnol 2010; 28: 71-78.
26. Cheng CW, Bielby H, Licence D, et al., Quantitative cellular and molecular analysis of the effect of progesterone withdrawal in a murine model of decidualization. Biol Reprod 2007; 76: 871-883. (Pubitemid 46651228)
27. Georgiades P, Ogilvy S, Duval H, et al., VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 2002; 34: 251-256. (Pubitemid 35470699)
28. Luo F, Brooks DG, Ye H, et al., Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice. Oncogene 2007; 26: 4415-4427. (Pubitemid 47014468)
29. Soriano P,. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genet 1999; 21: 70-71. (Pubitemid 29036285)
30. Ireland H, Kemp R, Houghton C, et al., Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology 2004; 126: 1236-1246. (Pubitemid 38552788)
31. Vigano P, Mangioni S, Odorizzi MP, et al., Use of estrogen antagonists and aromatase inhibitors in endometriosis. Curr Opin Invest Drugs 2003; 4: 1209-1212. (Pubitemid 37420108)
32. Becker CM, Wright RD, Satchi-Fainaro R, et al., A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. Am J Pathol 2006; 168: 2074-2084. (Pubitemid 43825325)
33. Fortin M, Lepine M, Page M, et al., An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development. Fertil Steril 2003; 80 (Suppl 2): 832-838. (Pubitemid 37152401)
34. Wong WP, Tiano JP, Liu S, et al., Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci U S A 2010; 107: 13057-13062.
35. Wu R, Hendrix-Lucas N, Kuick R, et al., Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways. Cancer Cell 2007; 11: 321-333. (Pubitemid 46518315)
36. Tsuno A, Nasu K, Yuge A, et al., Decidualization attenuates the contractility of eutopic and ectopic endometrial stromal cells: implications for hormone therapy of endometriosis. J Clin Endocrinol Metab 2009; 94: 2516-2523.
37. Sparmann A, Bar-Sagi D,. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6: 447-458. (Pubitemid 39469981)
38. Furuya M, Suyama T, Usui H, et al., Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. Hum Pathol 2007; 38: 1676-1687. (Pubitemid 47589091)
39. Mantovani A, Allavena P, Sica A, et al., Cancer-related inflammation. Nature 2008; 454: 436-444.
40. Dinulescu DM, Ince TA, Quade BJ, et al., Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nature Med 2005; 11: 63-70. (Pubitemid 40215839)